Chlorpropamide

This classification denotes an anti-diabetic agent with the molecular formula C10H13ClN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) WTM2C3IL2X, chemically known as urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl- but more generally known as chlorpropamide, which bears US NIH Compound Identifier 2727. European Medicines Agency schedules Chlorpropamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06209MIG. The term CHLORPROPAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4) WHO schedules chlorpropamide in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORPROPAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule chlorpropamide under HS 29350090 and SITC 51580. As of Q4 2014, CHLORPROPAMIDE remains US FDA's Preferred Term for this commodity. Chlorpropamide bears US NLM identifiers UMLS ID C0008287 and NCI Concept Code C47447. SMILES: CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)CL.